Mediwhale to Present Late-Breaking Data on Retinal-AI–Driven Cardiovascular Disease Prevention at AHA 2025

At this year’s American Heart Association (AHA) Scientific Sessions, Mediwhale will showcase how our groundbreaking AI—already being used in real-world clinical settings—detects early signs of cardiovascular disease through the retina.

Late-Breaking Science

Session: Deep learning derived coronary artery calcium from retinal images for prediction of cardiovascular disease in two different cohorts: Multi-Ethnic Study of Atherosclerosis (MESA) and Rotterdam Study (MERO)

• Presenter: Sahil Thakur
• Location: Room No. 243
• Date: Fri, Nov 7 
• Time: 4:15pm – 4:27pm CST

Moderated Posters

Session: Vascular Imaging for ASCVD Risk Stratification: Predictive Value of Carotid Plaque, Coronary Artery Calcium, and Retinal Biomarker (Dr.Noon CVD)

• Presenter: Chan Joo Lee
• Location: Population Science Zone
• Date: Sat, Nov 8
• Time: 2:41pm – 2:46pm CST
  

Session: Deep Learning-Based Retinal Biomarker Captures Cardiovascular Risk in Hypertensive Abnormal Dippers Beyond Conventional Metrics

• Presenter: Sahil Thakur
• Location: Population Science Zone
• Date: Mon, Nov 10
• Time: 12:43pm -12:48pm CST

Session: Retinal Vascular and Renal Biomarkers Predict Systemic Cardiovascular and Kidney Disease in the Brazilian Multilabel Ophthalmological Dataset (BRSET)

• Presenter: Sahil Thakur
• Location: Population Science Zone
• Date: Mon, Nov 10
• Time: 1:04pm – 1:09pm CST

Special Session / Invited Speaker

Session: Harnessing AI to Predict CKD Risk: A Game Changer in Early Detection

• Presenter: Young Su Joo
• Location: Rivergate
• Date: Sun, Nov 09
• Time:8:57am – 9:12am CST

Exhibition & Demo

Dr. Noon AI Screening Solutions (CVD Risk prediction) — Live demonstration  

• Location: No. 4021
• Date: Sat to Mon, Nov 8 to 10